Helping a precision medicine company implement rapid, scalable GxP Validation | Biopharma Company Case Study

A biopharmaceutical company using gene therapy faced escalating computer system validation (CSV) and GxP requirements as it deployed 25-30 SaaS application releases annually, requiring the reassignment of three full-time employees to validation work. Sware implemented its Res_Q platform along with expert functional support to centralize and automate validation processes company-wide. The partnership delivered approximately 102 FTE hours saved per validation project, eliminated paper-based processes, enabled rapid scaling, and maintained audit-readiness while freeing the core team for higher-priority initiatives.

Sware is a GxP validation platform whose entire commercial focus is life sciences — used specifically to validate AI/ML systems' explainable, traceable decisions for regulatory scrutiny.

This sits in the Scale & Govern stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to monitor, govern and keep validating an AI system once it is already live in production.